{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:03Z","timestamp":1788307743296,"version":"build-2803163510"},"reference-count":48,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["DNA and Cell Biology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>The coronavirus disease 2019 (COVID-19) public health crisis has reached critical mass, but interdisciplinary research efforts have provided the global community with the first effective medical intervention to fight the pandemic\u2014COVID-19 vaccines. Two of the vaccines approved for use in the United States and Europe deliver nucleic acid in the form of mRNA, the success of which would not be possible without biomaterials. Lipid nanoparticle (LNP)-based mRNA vaccines, discussed in this perspective, protect nucleic acids from degradation and deliver cargo directly to the intracellular compartment of cells where it is translated into the antigenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein that triggers protective immune responses. Despite success of LNP-based mRNA vaccines thus far, the pandemic has highlighted the need for emerging technologies that enable rapid development and increased accessibility to vaccination. Microneedle arrays, also discussed in this study, provide features that could lower barriers to vaccine access in resource-poor regions. The ability to exchange antigens within arrays could also facilitate swift vaccine deployment as public health needs evolve (e.g., in response to SARS-CoV-2 variants or entirely new pathogens). Therefore, the COVID-19 pandemic has spotlighted the readiness and value of biomaterials for the prevention and management of disease outbreaks.<\/jats:p>","DOI":"10.1089\/dna.2021.0538","type":"journal-article","created":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T11:15:25Z","timestamp":1640603725000},"page":"25-29","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response"],"prefix":"10.1177","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2246-7053","authenticated-orcid":false,"given":"Senta M.","family":"Kapnick","sequence":"first","affiliation":[{"name":"Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-019-0591-y"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31665-3"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2012.676038"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10063"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10143"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.11.019"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.035"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01392-2"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep06154"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102595118"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00283-5"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c07197"},{"key":"e_1_3_4_15_1","first-page":"MA","article-title":"US Patent No","author":"Ciaramella G.","year":"2020","unstructured":"Ciaramella G., , and Himansu S. (2020). US Patent No. 10,702,600 B1. Betacoronavirus mRNA Vaccine (Moderna, Inc.,, Cambridge, MA).","journal-title":"10,702,600 B1. Betacoronavirus mRNA Vaccine (Moderna, Inc.,"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10717541003667798"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-021-00912-9"},{"key":"e_1_3_4_18_1","first-page":"945","article-title":"Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine","volume":"7","author":"Hong X.","year":"2013","unstructured":"Hong X., , Wei L., , Wu F., , Wu Z., , Chen L., , Liu Z., et al. (2013). Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine. Drug Des Devel Ther, 7, 945\u2013952.","journal-title":"Drug Des Devel Ther"},{"key":"e_1_3_4_19_1","first-page":"1","article-title":"Lipid nanoparticles for mRNA delivery","volume":"10","author":"Hou X.","year":"2021","unstructured":"Hou X., , Tal Z., , Langer R., , and Dong Y. (2021). Lipid nanoparticles for mRNA delivery. Nat Rev Mater, 10, 1\u201317.","journal-title":"Nat Rev Mater"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-8"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.06.008"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310175200"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102743"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1189"},{"key":"e_1_3_4_26_1","first-page":"e10202","article-title":"Intradermal delivery of receptor-binding domain of SARS-CoV-2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice","author":"Kuwentrai C.","year":"2020","unstructured":"Kuwentrai C., , Yu J., , Rong L., , Zhang B.Z., , Hu Y.F., , Gong H.R., et al. (2020). Intradermal delivery of receptor-binding domain of SARS-CoV-2 spike protein with dissolvable microneedles to induce humoral and cellular responses in mice. Bioeng Transl Med 6, e10202.","journal-title":"Bioeng Transl Med 6,"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-021-01122-8"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/mi12040435"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0282-2"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0090-8"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.201800157"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9040320"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.07.039"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.017"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30575-5"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120586"},{"key":"e_1_3_4_38_1","first-page":"DC","article-title":"Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?","author":"Simmons-Duffin S.","year":"2021","unstructured":"Simmons-Duffin S. (2021). Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?. in Morning Edition. (National Public Radio,, Washington, DC).","journal-title":"in Morning Edition. (National Public Radio,"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00756-3"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(21)00084-5"},{"key":"e_1_3_4_41_1","unstructured":"United States Department of Health and Human Services (DHHS). (2019). COVID-19 Medical Countermeasures Portfolio. Available at https:\/\/www.medicalcountermeasures.gov\/app\/barda\/coronavirus\/COVID19.aspx Last accessed November12 2021."},{"key":"e_1_3_4_42_1","unstructured":"World Health Organization (WHO). (2012). WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available at https:\/\/covid19.who.int\/. Last accessed November12 2021."},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720542115"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.0c01363"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.9b01255"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c03252"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matt.2021.02.025"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.6b00414"}],"container-title":["DNA and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dna.2021.0538","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dna.2021.0538","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dna.2021.0538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:59:23Z","timestamp":1777399163000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dna.2021.0538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1089\/dna.2021.0538"],"URL":"https:\/\/doi.org\/10.1089\/dna.2021.0538","relation":{},"ISSN":["1044-5498","1557-7430"],"issn-type":[{"value":"1044-5498","type":"print"},{"value":"1557-7430","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}